Standardized SEC financial data for InfuSystem Holdings, Inc — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001337013 · NYSE · Surgical & Medical Instruments & Apparatus.
Ratios for fiscal year 2025, standardized from SEC filings.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $97.4M | $102.4M | $109.9M | $125.8M | $134.9M | $143.4M |
| Cost of revenue | $38.6M | $43.8M | $49.4M | $62.7M | $64.5M | $63.1M |
| Gross profit | $58.8M | $58.5M | $60.6M | $63.1M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.6M | $186K | $165K | $231K | $527K | $3.2M |
| Inventory | $3.0M | $3.9M | $4.8M | $6.4M | $6.5M | $5.4M |
| Total current assets | $29.8M | $22.1M | $24.8M | $30.6M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $20.3M | $18.3M | $17.5M | $11.2M | $20.5M | $24.4M |
| Capital expenditures | $1.1M | $980K | $982K | $1.0M | $1.1M | $560K |
| Free cash flow | $19.2M | $17.3M | $16.5M | $10.2M |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/INFU/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/INFU/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| $70.4M |
| $80.3M |
| SG&A expense | $35.2M | $40.7M | $44.2M | $45.4M | $51.2M | $57.0M |
| Operating income | $8.8M | $2.8M | $1.7M | $4.1M | $6.9M | $11.9M |
| EBITDA | $22.9M | $17.4M | $15.0M | $16.6M | $19.4M | $25.2M |
| Interest expense | $1.3M | $1.4M | $1.4M | $2.2M | $1.7M | $1.2M |
| Pretax income | $7.5M | $1.3M | $130K | $1.9M | $5.1M | $10.6M |
| Income tax | $9.8M | $163K | $112K | $979K | $2.7M | $4.0M |
| Net income | $17.3M | $1.4M | $18K | $872K | $2.3M | $6.6M |
| EPS (diluted) | $0.80 | $0.06 | $0.00 | $0.04 | $0.11 | $0.31 |
Standardized from InfuSystem Holdings, Inc's SEC filings — per-share figures split-adjusted. Full history via the API.
| $32.2M |
| $36.3M |
| Property, plant & equipment | $4.3M | $4.5M | $4.4M | $4.3M | $4.0M | $3.4M |
| Goodwill | $0 | $3.7M | $3.7M | $3.7M | $3.7M | $3.7M |
| Total assets | $97.0M | $97.6M | $99.4M | $102.9M | $103.6M | $100.6M |
| Total current liabilities | $23.0M | $12.9M | $14.5M | $15.7M | $17.7M | $20.2M |
| Long-term debt | $38.8M | $33.1M | $33.2M | $29.1M | $23.9M | $19.6M |
| Total debt | $48.2M | $33.4M | $33.2M | $29.1M | $23.9M | $19.6M |
| Total liabilities | $56.2M | $49.3M | $51.4M | $50.6M | $46.1M | $43.2M |
| Retained earnings | -$44.0M | -$53.9M | -$59.3M | -$58.6M | -$57.5M | -$60.7M |
| Total equity | $40.8M | $48.3M | $48.0M | $52.3M | $57.5M | $57.3M |
| $19.4M |
| $23.8M |
| Investing cash flow | -$12.2M | -$21.3M | -$11.5M | -$6.7M | -$13.2M | -$6.8M |
| Financing cash flow | -$1.1M | -$6.5M | -$6.1M | -$4.4M | -$6.9M | -$15.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Share repurchases | $0 | $560K | $5.5M | $153K | $1.2M | $9.9M |